1. Lee SJ. Classification systems for chronic graft-versus-host disease. Blood. 2017;129:30-7.

https://doi.org/10.1182/blood-2016-07-686642

PMid:27821503 PMCid:PMC5216262

2. Shazib MA, Muhlbauer J, Schweiker R, Li S, Cutler C, Treister N. Long-term utilization patterns of topical therapy and clinical outcomes of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2020;26:373-9.

https://doi.org/10.1016/j.bbmt.2019.09.029

PMid:31585167 

3. Mawardi H, Hashmi SK, Elad S, Aljurf M, Treister N. Chronic graft-versus-host disease: Current management paradigm and future perspectives. Oral Dis. 2019;25:931-48.

https://doi.org/10.1111/odi.12936

PMid:29984442 

4. Treister N, Chai X, Kurland B, Pavletic S, Weisdorf D, Pidala J, et al. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium. Bone Marrow Transplant. 2013;48:1123-8.

https://doi.org/10.1038/bmt.2012.285

PMid:23353804 PMCid:PMC3971477

5. Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB. Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14:110-5.

https://doi.org/10.1016/j.bbmt.2007.06.017

PMid:18158967 

6. Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, et al. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015;94:547-54.

https://doi.org/10.1177/0022034515570942

PMid:25740857 PMCid:PMC4485216

7. Fassil H, Bassim CW, Mays J, Edwards D, Baird K, Steinberg SM, et al. Oral chronic graft-vs.-host disease characterization using the NIH scale. J Dent Res. 2012;91:45S-51S.

https://doi.org/10.1177/0022034512450881

PMid:22699667 PMCid:PMC6728450

8. Kuten-Shorrer M, Woo SB, Treister NS. Oral graft-versus-host disease. Dent Clin North Am. 2014;58:351-68.

https://doi.org/10.1016/j.cden.2013.12.007

PMid:24655527 

9. Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am. 2008;52:79-109.

https://doi.org/10.1016/j.cden.2007.10.004

PMid:18154866 

10. Mays JW, Fassil H, Edwards DA, Pavletic SZ, Bassim CW. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013;19:327-46.

https://doi.org/10.1111/odi.12028

PMid:23107104 PMCid:PMC3561479

11. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-56.

https://doi.org/10.1016/j.bbmt.2005.09.004

PMid:16338616 

12. Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transplant. 2015;21:984-99.

https://doi.org/10.1016/j.bbmt.2015.02.025

PMid:25796139 PMCid:PMC4744804

13. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21:389-401 e1.

https://doi.org/10.1016/j.bbmt.2014.12.001

PMid:25529383 PMCid:PMC4329079

14. Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med. 1992;21:456-8.

https://doi.org/10.1111/j.1600-0714.1992.tb00974.x

PMid:1460584 

15. Haverman TM, Raber-Durlacher JE, Raghoebar II, Rademacher WMH, Rozema FR, Hazenberg MD, et al. Oral chronic graft-versus-host disease: What the general dental practitioner needs to know. J Am Dent Assoc. 2020;151:846-56.

https://doi.org/10.1016/j.adaj.2020.08.001

PMid:33121606 

16. Carpenter PA, Kitko CL, Elad S, Flowers ME, Gea-Banacloche JC, Halter JP, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant. 2015;21:1167-87.

https://doi.org/10.1016/j.bbmt.2015.03.024

PMid:25838185 PMCid:PMC4821166

17. Treister N, Duncan C, Cutler C, Lehmann L. How we treat oral chronic graft-versus-host disease. Blood. 2012;120:3407-18.

https://doi.org/10.1182/blood-2012-05-393389

PMid:22898605 

18. Pengpis N, Prueksrisakul T, Chanswangphuwana C. Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria. Med Oral Patol Oral Cir Bucal. 2023;28:e167-73.

https://doi.org/10.4317/medoral.25629

PMid:36173715 PMCid:PMC9985937

19. Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther. 2021;27:817-35.

https://doi.org/10.1016/j.jtct.2021.06.001

PMid:34217703 PMCid:PMC8478861